ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Asieris Announces First Patient Treated in Europe in APRICITY, the Multinational Phase III Clinical Trial of APL-1702, Cevira®
June 22, 2021Asieris Pharmaceuticals (Asieris) today announced dosing of the first patient in Europe in its multinational, multicenter, Phase III clinical trial (APRICITY) of its photodynamic drug-device combination product APL-1702, Cevira® which is being ... -
Cervical dysplasia treatment device approved for global Phase III trial
July 10, 2020The cervical dysplasia drug-device product, APL-1702 (Cevira®), offers an alternative to surgery and has been approved to start a clinical trial in China and several other countries.
Pharma Sources Insight January 2025
